These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11605931)

  • 21. Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 2000 Feb; 92(2):376-86. PubMed ID: 10691223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset/offset characteristics and intubating conditions of rapacuronium: a comparison with rocuronium.
    Zhou TJ; White PF; Chiu JW; Joshi GP; Dullye KK; Duffy LL; Tongier WK
    Br J Anaesth; 2000 Aug; 85(2):246-50. PubMed ID: 10992833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapacuronium and the risk of bronchospasm in pediatric patients.
    Rajchert DM; Pasquariello CA; Watcha MF; Schreiner MS
    Anesth Analg; 2002 Mar; 94(3):488-93; table of contents. PubMed ID: 11867363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolongation of rapacuronium neuromuscular blockade by clindamycin and magnesium.
    Sloan PA; Rasul M
    Anesth Analg; 2002 Jan; 94(1):123-4, table of contents. PubMed ID: 11772813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular rapacuronium in infants and children: dose-ranging and tracheal intubating conditions.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 1999 Nov; 91(5):1285-92. PubMed ID: 10551578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mivacurium--a new muscle relaxant compared with atracurium and vecuronium].
    Scholz J; von Knobelsdorff G; Peters K; Kycia B; Schulte am Esch J
    Anaesthesiol Reanim; 1997; 22(4):95-9. PubMed ID: 9376044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramuscular rapacuronium in infants and children: a comparative multicenter study to confirm the efficacy and safety of the age-related tracheal intubating doses of intramuscular rapacuronium (ORG 9487) in two groups of pediatric subjects.
    Denman WT; Kaplan RF; Goudsouzian NG; Uejima T; Barcelona SL; Cote CJ; Ginsberg B; Hannallah RS
    Anesthesiology; 2001 Jan; 94(1):3-7. PubMed ID: 11135715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atracurium, vecuronium, and intraocular pressure in humans.
    Schneider MJ; Stirt JA; Finholt DA
    Anesth Analg; 1986 Aug; 65(8):877-82. PubMed ID: 2873760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.
    Larijani GE; Zafeiridis A; Goldberg ME
    Pharmacotherapy; 1999 Oct; 19(10):1118-22. PubMed ID: 10512060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early reversal of rapacuronium with neostigmine.
    Purdy R; Bevan DR; Donati F; Lichtor JL
    Anesthesiology; 1999 Jul; 91(1):51-7. PubMed ID: 10422928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium.
    Proost JH; Wright PM
    Eur J Anaesthesiol Suppl; 2001; 23():83-9. PubMed ID: 11766253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemodynamic effects of rapacuronium in adults with coronary artery or valvular disease.
    McCourt KC; Elliott P; Mirakhur RK; McMurray TJ; Phillips AS; Cochrane D
    Br J Anaesth; 1999 Nov; 83(5):721-6. PubMed ID: 10690133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter evaluation of the time-course of action of two doses of rapacuronium after early and late reversal with neostigmine.
    Larijani GE; Donati F; Bikhazi G; Bartkowski R; Kenaan CA; Plaud B; Goldberg ME
    Anesth Analg; 2001 Aug; 93(2):370-4 , 3rd contents page. PubMed ID: 11473863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapacuronium: first experience in clinical practice.
    Bartkowski RR; Witkowski TA
    Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
    Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapacuronium preferentially antagonizes the function of M2 versus M3 muscarinic receptors in guinea pig airway smooth muscle.
    Jooste E; Zhang Y; Emala CW
    Anesthesiology; 2005 Jan; 102(1):117-24. PubMed ID: 15618795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The non-depolarizing myorelaxants in orotracheal intubation. A clinical comparison].
    Ravagnan R; Russo R; Buzzetti V; Elena A; Colombo A; Pelosi P; Iapichino G
    Minerva Anestesiol; 1989 Nov; 55(11):467-71. PubMed ID: 2576685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion.
    Fisher DM; Dempsey GA; Atherton DP; Brown R; Abengochea A; Hunter JM
    Anesthesiology; 2000 Dec; 93(6):1384-91. PubMed ID: 11149430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.